SCHEMBL6353585

SCHEMBL6353585

Cc1cc(-c2cc[c]cc2)nn1C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
CYP1A2 P05177 2/20 0.38
CYP3A4 P08684 2/20 0.38
MAPT P10636 3/20 0.36
APOBEC3G Q9HC16 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
ESRRA P11474 1/20 0.36
NPC1 O15118 6/20 0.34
RAB9A P51151 6/20 0.34
KDM4E B2RXH2 3/20 0.34
CYP11B1 P15538 2/20 0.34
CYP11B2 P19099 2/20 0.34
BAZ2B Q9UIF8 1/20 0.33
POLB P06746 1/20 0.33
HDAC6 Q9UBN7 1/20 0.32
MEN1 O00255 1/20 0.32
TP53 P04637 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14996633 0.80 SMN1; SMN2 (0.51) ALDH1A1SMN1; SMN2CYP1A2CYP3A4MAPT
SCHEMBL5280031 0.80 RAB9A (0.51) ALDH1A1SMN1; SMN2MAPTNPC1RAB9A
SCHEMBL22130283 0.79 BRD4 (0.48) CYP3A4MAPTESRRAPOLB
SCHEMBL19145066 0.78 DYRK1A (0.41) ALDH1A1SMN1; SMN2CYP1A2CYP3A4MAPT
SCHEMBL16202036 0.77 ALDH1A1 (0.52) ALDH1A1SMN1; SMN2MAPTAPOBEC3GTDP1
SCHEMBL12988852 0.77 ESRRA (0.56) ALDH1A1SMN1; SMN2CYP1A2CYP3A4MAPT
SCHEMBL14091695 0.77 NPC1 (0.54) ALDH1A1SMN1; SMN2MAPTNPC1RAB9A
SCHEMBL31617619 0.76 MAPT (0.41) ALDH1A1SMN1; SMN2CYP1A2CYP3A4MAPT
SCHEMBL23329066 0.74 TMEM97 (0.44) ALDH1A1SMN1; SMN2CYP1A2CYP3A4MAPT
SCHEMBL14996562 0.74 ADORA3 (0.40) ALDH1A1SMN1; SMN2CYP1A2CYP3A4MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050101783-A1 N-(heterocycle-methyl)alkylamine derivative, process for producing the same, and bactericide KUREHA CORPORATION (JP) 2005-05-12 US disclosed
US-4472421-A SHAMPOO BAYER AKTIENGESELLSCHAFT (DE) 1984-09-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050101783-A1 N-(heterocycle-methyl)alkylamine derivative, process for producing the same, and bactericide HBZ, ACMSD, HDHD5 ALDH1A1 4359/4885SMN1; SMN2 4784/4885CYP1A2 2399/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.